Please assess the completion status of the following clinical trial:

Trial Title: Bronchoscopy and Bispectral Index (BIS) - Guided Sedation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients scheduled for bronchoscopy~* ASA I to III~* age between 18 and 79 years~* capacity of discernment~Exclusion Criteria:~* visual and psychological problems that might interfere with psychometric testing~* chronic obstructive pulmonary disease with FEV1 \< 50% predicted~* need for an airway intubation or laryngeal mask insertion~* fever or other signs of systemic infection~* hemodynamic instability defined as a resting heart rate (HR) \< 60 or ≥ 120 and/or a systolic blood pressure (BP) \< 100 or \> 180 mmHg~* significant liver disease and documented soy allergy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: t

Study Arms:
- Midazolam (Type: ACTIVE_COMPARATOR): i.v. midazolam titration until adequate depth of sedation
- Propofol (Type: ACTIVE_COMPARATOR): i.v. propofol titration until adequate depth of sedation

Based on this trial design, predict the completion outcome and termination type (if applicable).